E
NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
E
Sell
6/13/2024Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/13/2024 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/13/2024 due to a decline in the volatility index.
D
Sell
6/7/2024Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 6/7/2024 due to a substantial increase in the valuation index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 6/7/2024 due to a substantial increase in the valuation index and volatility index.
E
Sell
5/23/2024Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 5/23/2024 due to a decline in the volatility index, total return index and valuation index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 5/23/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
4/3/2024Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 4/3/2024 due to an increase in the total return index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 4/3/2024 due to an increase in the total return index and volatility index.
E
Sell
3/19/2024Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 3/19/2024 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 3/19/2024 due to a decline in the volatility index.
D
Sell
3/4/2024Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 3/4/2024 due to an increase in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 3/4/2024 due to an increase in the volatility index.
E
Sell
11/9/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index.
D
Sell
10/25/2023Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 10/25/2023 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 10/25/2023 due to an increase in the volatility index and total return index.
E
Sell
8/15/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 8/15/2023 due to a decline in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 8/15/2023 due to a decline in the volatility index and total return index.
D
Sell
7/26/2023Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
E
Sell
6/21/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.04 to 0.03.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.04 to 0.03.
D
Sell
5/15/2023Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 5/15/2023 due to an increase in the valuation index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 5/15/2023 due to an increase in the valuation index and total return index.
E
Sell
3/14/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 03/14/2023.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/9/2023Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
2/6/2023Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 2/6/2023 due to a decline in the total return index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 2/6/2023 due to a decline in the total return index and volatility index.
D
Sell
1/20/2023Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 1/20/2023 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 1/20/2023 due to an increase in the volatility index and total return index.
D
Sell
12/28/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 12/28/2022 due to a decline in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 12/28/2022 due to a decline in the volatility index and total return index.
D
Sell
12/13/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 12/13/2022 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 12/13/2022 due to an increase in the volatility index and total return index.
D
Sell
11/25/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 11/25/2022 due to a decline in the valuation index, volatility index and solvency index. The quick ratio declined from 0.07 to 0.05.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 11/25/2022 due to a decline in the valuation index, volatility index and solvency index. The quick ratio declined from 0.07 to 0.05.
D
Sell
11/11/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 11/11/2022 due to an increase in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 11/11/2022 due to an increase in the volatility index.
D
Sell
10/26/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 10/26/2022 due to a decline in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 10/26/2022 due to a decline in the volatility index and total return index.
D
Sell
10/10/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 10/10/2022 due to an increase in the volatility index and valuation index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 10/10/2022 due to an increase in the volatility index and valuation index.
D
Sell
9/23/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 9/23/2022 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 9/23/2022 due to a decline in the volatility index.
D
Sell
9/8/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 9/8/2022 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 9/8/2022 due to an increase in the volatility index and total return index.
D
Sell
8/23/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 8/23/2022 due to a decline in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 8/23/2022 due to a decline in the volatility index and total return index.
D
Sell
8/4/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 8/4/2022 due to a large increase in the growth index and solvency index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 8/4/2022 due to a large increase in the growth index and solvency index.
D
Sell
8/3/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 8/3/2022 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 8/3/2022 due to an increase in the volatility index and total return index.
E
Sell
7/19/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 7/19/2022 due to a decline in the volatility index and valuation index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 7/19/2022 due to a decline in the volatility index and valuation index.
D
Sell
6/28/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 6/28/2022 due to an increase in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 6/28/2022 due to an increase in the volatility index.
E
Sell
6/10/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/10/2022 due to a decline in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 6/10/2022 due to a decline in the volatility index and total return index.
D
Sell
5/31/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 5/31/2022 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0182 to -$0.0068.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 5/31/2022 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0182 to -$0.0068.
D
Sell
5/16/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 05/16/2022.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index.
D
Sell
5/4/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell
5/1/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 05/01/2022.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/26/2022Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 4/26/2022 due to a large increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0573 to $0.0162, and operating cash flow increased 49.87% from -$39.3 to -$19.7.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 4/26/2022 due to a large increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0573 to $0.0162, and operating cash flow increased 49.87% from -$39.3 to -$19.7.
E
Sell
4/20/2022Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
D
Sell
12/1/2021Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 12/1/2021 due to a noticeable increase in the solvency index and valuation index. The quick ratio increased from 0 to 0.13.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E+ on 12/1/2021 due to a noticeable increase in the solvency index and valuation index. The quick ratio increased from 0 to 0.13.
E
Sell
9/3/2021Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 9/3/2021 due to a noticeable decline in the growth index and total return index. EBIT declined 120% from -$61 to -$134.2, and earnings per share declined from -$0.0123 to -$0.0235.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 9/3/2021 due to a noticeable decline in the growth index and total return index. EBIT declined 120% from -$61 to -$134.2, and earnings per share declined from -$0.0123 to -$0.0235.
D
Sell
8/25/2021Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 8/25/2021 due to a decline in the total return index, valuation index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 8/25/2021 due to a decline in the total return index, valuation index and volatility index.
D
Sell
6/2/2021Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 6/2/2021 due to a substantial increase in the growth index and total return index. Earnings per share increased from -$0.0017 to -$0.0006, and EBIT increased 59.06% from -$149 to -$61.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from E+ on 6/2/2021 due to a substantial increase in the growth index and total return index. Earnings per share increased from -$0.0017 to -$0.0006, and EBIT increased 59.06% from -$149 to -$61.
E
Sell
5/3/2021Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 5/3/2021 due to a significant decline in the solvency index and growth index. Operating cash flow declined 350% from $1.6 to -$4, earnings per share declined from -$0.0006 to -$0.0017, and EBIT declined 132.81% from -$64 to -$149.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E+ from D- on 5/3/2021 due to a significant decline in the solvency index and growth index. Operating cash flow declined 350% from $1.6 to -$4, earnings per share declined from -$0.0006 to -$0.0017, and EBIT declined 132.81% from -$64 to -$149.
D
Sell
11/21/2019Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 11/21/2019 due to a decline in the valuation index, total return index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 11/21/2019 due to a decline in the valuation index, total return index and volatility index.
D
Sell
11/6/2019Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 11/6/2019 due to an increase in the valuation index.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 11/6/2019 due to an increase in the valuation index.
D
Sell
7/29/2019Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 7/29/2019 due to a decline in the total return index and volatility index.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 7/29/2019 due to a decline in the total return index and volatility index.
D
Sell
5/29/2019Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 5/29/2019 due to a substantial increase in the growth index and valuation index. Total revenue increased 148.77% from -$543.6 to $265.1, EBIT increased 73.39% from -$1.34M to -$356.4, and earnings per share increased from -$0.0211 to -$0.01.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 5/29/2019 due to a substantial increase in the growth index and valuation index. Total revenue increased 148.77% from -$543.6 to $265.1, EBIT increased 73.39% from -$1.34M to -$356.4, and earnings per share increased from -$0.0211 to -$0.01.
D
Sell
5/1/2019Downgrade
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 5/1/2019 due to a large decline in the growth index, solvency index and valuation index. Total revenue declined 243.01% from $380.1 to -$543.6, earnings per share declined from -$0.0067 to -$0.0211, and EBIT declined 184.85% from -$470.1 to -$1.34M.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to D- from D on 5/1/2019 due to a large decline in the growth index, solvency index and valuation index. Total revenue declined 243.01% from $380.1 to -$543.6, earnings per share declined from -$0.0067 to -$0.0211, and EBIT declined 184.85% from -$470.1 to -$1.34M.
D
Sell
4/9/2019Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 4/9/2019 due to a large increase in the solvency index, total return index and growth index. Total revenue increased 88.73% from $201.4 to $380.1, operating cash flow increased 27.13% from -$856.1 to -$623.8, and earnings per share increased from -$0.0084 to -$0.0067.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D from D- on 4/9/2019 due to a large increase in the solvency index, total return index and growth index. Total revenue increased 88.73% from $201.4 to $380.1, operating cash flow increased 27.13% from -$856.1 to -$623.8, and earnings per share increased from -$0.0084 to -$0.0067.
D
Sell
9/4/2018Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E on 9/4/2018 due to an increase in the efficiency index, growth index and volatility index. Operating cash flow increased 22.59% from -$1.11M to -$856.1, earnings per share increased from -$0.0103 to -$0.0085, and net income increased 17.35% from -$995.2 to -$822.5.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to D- from E on 9/4/2018 due to an increase in the efficiency index, growth index and volatility index. Operating cash flow increased 22.59% from -$1.11M to -$856.1, earnings per share increased from -$0.0103 to -$0.0085, and net income increased 17.35% from -$995.2 to -$822.5.
E
Sell
6/5/2018Upgraded
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to E from E- on 6/5/2018 due to a noticeable increase in the solvency index, growth index and valuation index. Earnings per share increased from -$0.0967 to -$0.0103, and the quick ratio increased from 22.39 to 39.18.
NanoSphere Health Sciences Inc. (NSHSF) was upgraded to E from E- on 6/5/2018 due to a noticeable increase in the solvency index, growth index and valuation index. Earnings per share increased from -$0.0967 to -$0.0103, and the quick ratio increased from 22.39 to 39.18.
E
Sell
3/8/2018None
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E- from U on 03/08/2018.
NanoSphere Health Sciences Inc. (NSHSF) was downgraded to E- from U on 03/08/2018.
OTC PK
04/03/2025 11:39AM Eastern
Quotes delayed
